Abstract

Program Leadership The CGE Program leadership consists of two basic scientists (Drs. Doetsch and Vertino) and one physician-scientist (Dr. Petros). Dr. Paul Doetsch has been associated with the Winship Cancer Institute and the leadership and development of its scientific programs for many years. He is the Program Director of a Program Project Grant, 'Cellular Responses to Genotoxic Stress' and has a long track record of R01 grant support from the NCI. Dr. Doetsch has served in the past as a regular member of the Radiation Study Section at the NIH and the Carcinogenesis, Nutrition and Environment study section of the American Cancer Society. He is internationally recognized for his studies and publications in the areas of DNA damage repair, mutagenesis and genetic instability. Over a decade ago, he discovered transcriptional mutagenesis and has been a pioneer in this area and its leading authority. He is the co-editor of a recent (2006) textbook, 'DNA Damage Recognition' and has trained dozens of Ph.D. students and postdoctoral fellows. He serves on several important School of Medicine advisory committees, including the Research Advisory Council (RAC).

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA138292-03
Application #
8249475
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2012-07-31
Budget Start
2011-04-01
Budget End
2012-07-31
Support Year
3
Fiscal Year
2011
Total Cost
$219,786
Indirect Cost

  Institution

Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322

  Publications

Cassidy, Richard J; Zhang, Xinyan; Switchenko, Jeffrey M et al. (2018) Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer 124:775-784
Xiao, Canhua; Beitler, Jonathan J; Higgins, Kristin A et al. (2018) Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain Behav Immun 74:291-295
Jhaveri, Jaymin; Rayfield, Lael; Liu, Yuan et al. (2018) Impact of intensity modulated radiation therapy on survival in anal cancer. J Gastrointest Oncol 9:618-630
Jhaveri, Jaymin; Chowdhary, Mudit; Zhang, Xinyan et al. (2018) Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. J Neurosurg :1-7
Chowdhary, Mudit; Switchenko, Jeffrey M; Press, Robert H et al. (2018) Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neurooncol 139:689-697
Bilen, Mehmet Asim; Dutcher, Giselle Marie Almeida; Liu, Yuan et al. (2018) Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clin Genitourin Cancer 16:e563-e575
Morgan, T M; Wang, X; Qian, X et al. (2018) Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes. Clin Transl Oncol :
Lin, Songbai; Han, Yiran; Jenkin, Kayte et al. (2018) Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis. Am J Pathol 188:353-366
Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5
Bekhbat, Mandakh; Chu, Karen; Le, Ngoc-Anh et al. (2018) Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology 98:222-229

Showing the most recent 10 out of 331 publications